Analysts' Top Healthcare Picks: NewAmsterdam Pharma Company (NAMS), Elanco Animal Health (ELAN)
Johnson & Johnson Analyst Ratings
Johnson & Johnson (JNJ) Receives a Buy From RBC Capital
Analysts Have Conflicting Sentiments on These Healthcare Companies: Cytek Biosciences (CTKB), Elanco Animal Health (ELAN) and Atara Biotherapeutics (ATRA)
Eli Lilly and Co Analyst Ratings
Argus Adjusts Price Target on Eli Lilly to $840 From $770
Redburn Atlantic Adjusts Eli Lilly Price Target to $600 From $540
Elanco Animal Health Analyst Ratings
Piper Sandler Remains a Hold on Elanco Animal Health (ELAN)
Redburn Atlantic Adjusts Price Target on Pfizer to $27 From $26, Keeps Neutral Rating
Catalent's Resilient Growth and Positive Outlook Reinforce Buy Rating
Buy Rating Affirmed on Intra-Cellular Therapies Amid Strong Sales and Promising Clinical Trials
Elanco Animal Health Analyst Ratings
Analysts Offer Insights on Healthcare Companies: Legend Biotech (LEGN), IGM Biosciences (IGMS) and Elanco Animal Health (ELAN)
RBC Capital Sticks to Their Hold Rating for Catalent (CTLT)
Analysts' Top Healthcare Picks: Elanco Animal Health (ELAN), Syndax Pharmaceuticals (SNDX)
Analyst Ratings For Intra-Cellular Therapies
China Merchants Initiates Eli Lilly at Buy Rating With $852 Price Target
Perrigo's Resilience Amidst Challenges: A Buy Rating Based on Recovery Prospects and Growth Opportunities
Mizuho Maintains Buy on Axsome Therapeutics, Lowers Price Target to $106